NO20071481L - Aren-ruthenium (II)-forbindelser og deres anvendelse i kreftterapi - Google Patents

Aren-ruthenium (II)-forbindelser og deres anvendelse i kreftterapi

Info

Publication number
NO20071481L
NO20071481L NO20071481A NO20071481A NO20071481L NO 20071481 L NO20071481 L NO 20071481L NO 20071481 A NO20071481 A NO 20071481A NO 20071481 A NO20071481 A NO 20071481A NO 20071481 L NO20071481 L NO 20071481L
Authority
NO
Norway
Prior art keywords
donor
carbocyclic
ruthenium
aren
compounds
Prior art date
Application number
NO20071481A
Other languages
English (en)
Inventor
Abraha Habtemariam
Peter John Sadler
Original Assignee
Univ Edinburgh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Edinburgh filed Critical Univ Edinburgh
Publication of NO20071481L publication Critical patent/NO20071481L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/0006Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
    • C07F15/0046Ruthenium compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/28Compounds containing heavy metals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

En rutenium (II) forbindelse ifølge formel (1):. eller et solvat eller promedikament derav, hvor,,, R, Rog Rvelges uavhengig fra H, C-yalkyl, C.aryl, C.heterosyklyl, halo, ester, amido, acyl, sulfo, sulfonamido, eter, tioeter, azo, amino, eller Rog Rdanner sammen med ringen som de er knyttet til, en mettet eller umettet karbosyklisk eller heterosyklisk gruppe som inneholder opptil tre 3- til 8- leddede karbosykliske eller heterosykliske ringer, hvor hver enkelt karbosyklisk eller heterosyklisk ring kan sammenslåes til en eller flere andre karbosykliske eller heterosykliske ringer; X er en nøytral eller negativt ladet N- eller S- donorligand; Y er et motion; m er 0 eller 1; q er 1, 2 eller 3; C er C_alkylen bundet til A-grupper; p er 0 eller 1 og r er 1 når p er 0 og r er 2 når p er 1; og A og B er hver uavhengige O-donor-, N-donor- eller S-donorligander, og kan bindes sammen med hverandre.
NO20071481A 2004-08-20 2007-03-20 Aren-ruthenium (II)-forbindelser og deres anvendelse i kreftterapi NO20071481L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0418643.3A GB0418643D0 (en) 2004-08-20 2004-08-20 Ruthenium (II) compounds
PCT/GB2005/003242 WO2006018649A1 (en) 2004-08-20 2005-08-19 Arene ruthenium (ii) compounds and their use in cancer therapy

Publications (1)

Publication Number Publication Date
NO20071481L true NO20071481L (no) 2007-05-16

Family

ID=33042406

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20071481A NO20071481L (no) 2004-08-20 2007-03-20 Aren-ruthenium (II)-forbindelser og deres anvendelse i kreftterapi

Country Status (12)

Country Link
EP (1) EP1786412A1 (no)
JP (1) JP2008510693A (no)
KR (1) KR20070060091A (no)
CN (1) CN101043885A (no)
AU (1) AU2005273726A1 (no)
BR (1) BRPI0514430A (no)
CA (1) CA2578280A1 (no)
GB (1) GB0418643D0 (no)
MX (1) MX2007002099A (no)
NO (1) NO20071481L (no)
WO (1) WO2006018649A1 (no)
ZA (1) ZA200702093B (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102006017594A1 (de) 2006-04-13 2007-10-18 Wacker Chemie Ag Neuartige Ru-Komplexe, deren Herstellung und Verwendung
EP2016085B9 (en) 2006-05-09 2015-12-30 Ecole Polytechnique Fédérale de Lausanne (EPFL) Transition metal complexes for inhibiting resistance in the treatment of cancer and metastasis
GB0711849D0 (en) 2007-06-19 2007-07-25 Oxford Biosensors Ltd Redox Mediators
EP2067771A1 (en) 2007-12-03 2009-06-10 EPFL Ecole Polytechnique Fédérale de Lausanne Derivatives of Dihydroxypyrrolidine as Anti-Cancer Compounds
EP2409697A1 (en) 2010-07-20 2012-01-25 Université de Neuchâtel Medicaments Based on Dinuclear Ruthenium, Osmium and Iron Complexes Comprising Triply Bridging Thiolato, Selenolato, Alkoxo and/or Amido Ligands
WO2013038395A1 (en) 2011-09-16 2013-03-21 Universidade De Lisboa Transition metal complexes for pharmaceutical applications
WO2013136296A2 (en) 2012-03-14 2013-09-19 Universidade De Lisboa Water-soluble organometallic ruthenium and iron compunds presenting heteroaromatic ligands
RU2682674C2 (ru) 2013-03-15 2019-03-20 Шерри Энн МАКФАРЛЭНД Координационные комплексы на основе металлов в качестве фотодинамических соединений и их применение
US9751081B2 (en) 2014-12-01 2017-09-05 Clemson University Self-regenerating antioxidant catalysts and methods of using the same

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19736152A1 (de) * 1997-08-14 1999-02-18 Martin Wehlan Azido-Aziridinkomplexe, Verfahren zu ihrer Herstellung und ihre Verwendung
EP1224192B1 (en) * 1999-10-27 2005-08-31 The University Court, The University Of Edinburgh Half-sandwich ruthenium (ii) compounds comprising nitrogen containing ligands for treatment of cancer
GB0016052D0 (en) * 2000-06-30 2000-08-23 Univ Edinburgh Ruthenium (II) compounds
GB0215526D0 (en) * 2002-07-05 2002-08-14 Univ Edinburgh Anticancer compounds

Also Published As

Publication number Publication date
WO2006018649A1 (en) 2006-02-23
CN101043885A (zh) 2007-09-26
AU2005273726A1 (en) 2006-02-23
JP2008510693A (ja) 2008-04-10
GB0418643D0 (en) 2004-09-22
MX2007002099A (es) 2007-04-24
EP1786412A1 (en) 2007-05-23
ZA200702093B (en) 2008-08-27
BRPI0514430A (pt) 2008-05-06
CA2578280A1 (en) 2006-02-23
KR20070060091A (ko) 2007-06-12

Similar Documents

Publication Publication Date Title
NO20071481L (no) Aren-ruthenium (II)-forbindelser og deres anvendelse i kreftterapi
RU2497807C2 (ru) Карбазольные соединения и терапевтические применения соединений
RS51725B (en) N-METHYLAMINOMETHYL ISOINDOL COMPOUNDS AND COMPOSITIONS CONTAINING THEM AND USING THE SAME
EA201490580A1 (ru) Пирролбензодиазепины и их конъюгаты
NO992336L (no) Raf-kinase-inhibitorer
EA200701779A1 (ru) Производные (1,5-дифенил-1н-пиразол-3-ил)оксадиазола, их получение и их применение в терапии
BRPI0508464B8 (pt) sulfonilpirróis, composição farmacêutica compreendendo os mesmos e uso dos mesmos
BR112014027143A2 (pt) pirrolobenzodiazepinas
RS51545B (en) THIAZOL PIRAZOLOPIRAMIDINS AS ANTAGONISTS OF CRF1 RECEPTORS
MY146614A (en) Shading composition
BRPI0906525A2 (pt) substâncias policrômicas e seu uso
WO2010104406A8 (en) Prodrug forms of kinase inhibitors and their use in therapy
EA201391324A1 (ru) Бис(фторалкил)-1,4-бензодиазепиноновые соединения
RU2017108785A (ru) Пестицидные композиции и связанные с ними способы
EA201390877A1 (ru) Замещенные 6,6-конденсированные азотсодержащие гетероциклические соединения и их применение
ATE524476T1 (de) Pyrazolopyrimidine als modulatoren von caseinkinase ii (ck2)
CL2009000323A1 (es) Compuestos derivados de heterociclos no condensados sustituidos, inhibidores de la funcion de la proteina ns5a; composicion farmaceutica que los comprende; y su uso para tratar la infeccion del virus de la hepatitis c.
ES2308299T3 (es) Tiadiazoles como ligandos de receptores de cxc-y cc-quimioquinas.
ECSP056063A (es) 6-alquil o alquenil-4-aminopicolinatos y uso de los mismos como herbicidas
ATE529399T1 (de) Sanfte anticholinerge ester
EA200401614A1 (ru) O-замещённые гидроксиарильные производные
SE402216B (sv) Vattenhaltig emulsion av organisk isocyanater till anvendning som adhesiv, bindemedel och overdrag och sett for framstellning herav
JP2008510693A5 (no)
AR087701A1 (es) Derivados de pirazol con actividad inhibidora de sglt1
WO2009083608A9 (en) Quinazolines and related heterocyclic compounds, and their therapeutic use

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application